TCISF Financial Statements & Analysis
Complete financial statements for TCISF including income statement, balance sheet, and cash flow statement. Analyze TCISF's revenue growth, profit margins, earnings trends, debt levels, and cash flow generation.
Financial Health Score
Financial Health Score
Income Statement
Revenue
-5.1% ↓
Net Income
-17.3% ↓
Gross Margin
10.7% ↑
Operating Margin
27.9% ↑
Balance Sheet
Current Ratio
19.1% ↑
Debt to Equity
-59.6% ↑
Asset Turnover
-4.9% ↓
Cash Flow
Operating Cash Flow
40.0% ↑
Net Cash Flow
-110.3% ↓
Free Cash Flow
67.1% ↑
Cash Flow to Debt
216.3% ↑
Income Statement Comparison
Revenue & Net Income
Period Comparison
| Metric | 2025 | 2026 | Change | Impact |
|---|---|---|---|---|
| Revenue | 285.39B | 270.70B | 5.1% | |
| Gross Profit | 29.76B | 31.26B | 5.0% | |
| Operating Income | 9.63B | 11.68B | 21.3% | |
| Net Income | 11.31B | 9.36B | 17.3% | |
| EPS | 329.93 | 273.22 | 17.2% | |
| EBITDA | 21.59B | 16.83B | 22.0% | |
| Gross Margin | 10.43% | 11.55% | 10.7% | |
| Operating Margin | 3.37% | 4.31% | 27.9% | |
| Net Income Margin | 3.96% | 3.46% | 12.8% | |
| R&D Expenses | 0 | 0 | 0.0% |
Income Statement Full Table
Free users can view the last 3 periods. Upgrade to see the full history.
Upgrade| Metric | 2026 | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Revenue | 270.70B | 285.39B | 292.95B | — | — |
| Gross Profit | 31.26B | 29.76B | 28.41B | — | — |
| Operating Income | 11.68B | 9.63B | 7.21B | — | — |
| Net Income | 9.36B | 11.31B | 5.42B | — | — |
| EPS | 273.22 | 329.93 | 158.23 | — | — |
| EBITDA | 16.83B | 21.59B | 12.95B | — | — |
| Gross Margin | 11.55% | 10.43% | 9.70% | — | — |
| Operating Margin | 4.31% | 3.37% | 2.46% | — | — |
| Net Income Margin | 3.46% | 3.96% | 1.85% | — | — |
| R&D Expenses | 0 | 0 | 0 | — | — |
Financial Metrics
Want to dive deeper into TCISF's financial health? Explore key financial metrics and ratios including profitability, liquidity, efficiency, and valuation metrics.
View Financial Metrics